surmount-1 trial tirzepatide obesity without diabetes weight loss SURMOUNT 1 // Three-Year Obesty & Prevention Outcomes Tirzepatide may lead weight loss

Step-by-step reconstitution protocol This protocol assumes you're adding 2 mL of bacteriostatic water to create a 2.5 mg/mL solution

For example: 200 pounds 3050 pounds 250 pounds 3863 pounds Longer-term use supports more sustained results, especially when treatment is paired with adequate protein intake, muscle preservation, and ongoing monitoring

The Most Concerning Long-Term Risks of GLP-1 Drugs Below are the strongest areas of concern based on clinical observations, case reports, patient outcomes, and developing research

A neck lump, persistent hoarseness, difficulty swallowing, or thyroid nodule should be medically evaluated

At this time our providers believe that the use of this medication works best in conjuncture with added B12

A few notes for non-traditional eating windows: If you fast until noon or later, take WLP-1 before your first meal of the day, not at sunrise If you eat a small breakfast and a bigger lunch, lunch may be the better target If you struggle most with afternoon cravings or evening overeating, you can split your dose: one in the morning, one in the early afternoon The goal isn't a clock